| Model Number |
BXA113902A |
| Medical Device Problem Code |
Device-Device Incompatibility (2919)
|
| Health Effect - Clinical Code |
Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
| Date of Event |
07/29/2021
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
(b)(4).Additional manufacturing narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium apl, which in covalently bound to the device surface and is essentially|non-eluting.(b)(4).
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2021, this patient underwent endovascular treatment for aortic occlusive disease and was implanted with gore® excluder® conformable aaa endoprostheses.The trunk ipsilateral leg component deployed correctly but was positioned slightly higher than intended with partial coverage of the ostium of a renal artery.The device was reconstrained and the physician attempted to reposition but struggled with trying to reposition the cxt and chose to leave it as is and implant a gore® viabahn® vbx balloon expandable endoprosthesis (vbx) covered stent in one of the renal arteries to ensure good flow.During post-dilitation of the vbx with a coda balloon catheter the renal artery was ruptured due to believed over-inflation of the balloon.The patent expired intra-procedure, a cause of death was not provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated device details.
|
| |
|
Search Alerts/Recalls
|